Goldenwell Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.01	0.03	0.05	0.05	0.05	0.21
Cash & Short-Term Investments	0.01	0.03	0.05	0.05	0.05	0.21
Cash Growth	-21.68%	-45.80%	-7.19%	15.73%	-78.46%	-14.09%
Inventory	-	-	0.17	0.17	0.18	0.2
Prepaid Expenses	-	0.01	-	-	-	-
Total Current Assets	0.02	0.04	0.22	0.23	0.22	0.41
Property, Plant & Equipment	-	-	-	-	0.03	0.05
Total Assets	0.02	0.04	0.22	0.23	0.25	0.46
Accounts Payable	-	-	-	-	-	0.11
Current Portion of Leases	-	-	-	-	0.03	0.05
Current Unearned Revenue	0.1	0.1	0	0	0	-
Total Current Liabilities	0.1	0.1	0	0	0.03	0.16
Long-Term Debt	0.28	0.28	0.27	0.14	0.02	-
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	0.38	0.38	0.27	0.14	0.05	0.16
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1.3	1.3	1.3	1.3	1.3	0.42
Retained Earnings	-1.67	-1.66	-1.36	-1.23	-1.11	-0.13
Comprehensive Income & Other	-0	-	-	-	-	-0
Shareholders' Equity	-0.36	-0.34	-0.05	0.08	0.2	0.3
Total Liabilities & Equity	0.02	0.04	0.22	0.23	0.25	0.46
Total Debt	0.28	0.28	0.27	0.14	0.05	0.05
Net Cash (Debt)	-0.27	-0.25	-0.22	-0.09	0	0.17
Net Cash Growth	-	-	-	-	-99.62%	-33.31%
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	0.00	0.00
Filing Date Shares Outstanding	99	99	99	99	99	96
Total Common Shares Outstanding	99	99	99	99	99	96
Working Capital	-0.08	-0.07	0.22	0.23	0.2	0.25
Book Value Per Share	-0.00	-0.00	-0.00	0.00	0.00	0.00
Tangible Book Value	-0.36	-0.34	-0.05	0.08	0.2	0.3
Tangible Book Value Per Share	-0.00	-0.00	-0.00	0.00	0.00	0.00